A detailed history of Main Street Financial Solutions, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Main Street Financial Solutions, LLC holds 24,000 shares of URGN stock, worth $252,959. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,000
Previous 24,000 -0.0%
Holding current value
$252,959
Previous $402,000 24.38%
% of portfolio
0.03%
Previous 0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$12.72 - $19.2 $305,280 - $460,800
24,000 New
24,000 $402,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $240M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Main Street Financial Solutions, LLC Portfolio

Follow Main Street Financial Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Financial Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Financial Solutions, LLC with notifications on news.